Pyroglutamate Abeta as an Immunotherapeutic Target for AD
- Starts:
- 2:00 pm on Wednesday, February 13, 2013
- Ends:
- 3:20 pm on Wednesday, February 13, 2013
- Location:
- L-209/209
Cynthia A. Lemere, Ph.D., Associate Professor of Neurology, Harvard Medical School; Brigham & Women's Hospital, Center for Neurologic Diseases, will present her seminar "Pyroglutamate Abeta as an Immunotherapeutic Target for AD."
